Publication|Articles|November 1, 2024
- November 2024
- Volume 30
- Issue 12
Table Multiple Myeloma Trials November 2024
Author(s)Ryan Flinn, Mary Caffrey
Key Takeaways
Advertisement
TABLE. Multiple Myeloma: Enrollment of Black Patients in Trials Required for Initial FDA Approval
Articles in this issue
about 1 year ago
To Improve Clinical Trial Equity in Multiple Myeloma, Just Askabout 1 year ago
Advancing Equitable Access to Elevate Value-Based Cancer CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
4
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
5






































